| 000 | 01690 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516030549.0 | ||
| 264 | 0 | _c20111129 | |
| 008 | 201111s 0 0 eng d | ||
| 022 | _a1540-0514 | ||
| 024 | 7 |
_a10.1097/SHK.0b013e31821a4002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKandasamy, Kathirvel | |
| 245 | 0 | 0 |
_aAtorvastatin prevents vascular hyporeactivity to norepinephrine in sepsis: role of nitric oxide and α₁-adrenoceptor mRNA expression. _h[electronic resource] |
| 260 |
_bShock (Augusta, Ga.) _cJul 2011 |
||
| 300 |
_a76-82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAtorvastatin |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aGuanylate Cyclase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aHeptanoic Acids _xtherapeutic use |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 |
_aNorepinephrine _xadverse effects |
| 650 | 0 | 4 |
_aOxadiazoles _xpharmacology |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 |
_aPyrroles _xtherapeutic use |
| 650 | 0 | 4 |
_aQuinoxalines _xpharmacology |
| 650 | 0 | 4 | _aRNA, Messenger |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, alpha-1 _xgenetics |
| 650 | 0 | 4 |
_aSepsis _xdrug therapy |
| 650 | 0 | 4 |
_aVasoconstrictor Agents _xadverse effects |
| 700 | 1 | _aPrawez, Shahid | |
| 700 | 1 | _aChoudhury, Soumen | |
| 700 | 1 | _aMore, Amar Sunil | |
| 700 | 1 | _aAhanger, Azad Ahmed | |
| 700 | 1 | _aSingh, Thakur Uttam | |
| 700 | 1 | _aParida, Subhashree | |
| 700 | 1 | _aMishra, Santosh Kumar | |
| 773 | 0 |
_tShock (Augusta, Ga.) _gvol. 36 _gno. 1 _gp. 76-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/SHK.0b013e31821a4002 _zAvailable from publisher's website |
| 999 |
_c20683176 _d20683176 |
||